Thoracic Imaging Manifestations of Treated Lymphomas: Response Evaluation, Posttherapeutic Sequelae, and Complications

Cory R. Gooch, Manoj K. Jain, Milena Petranovic, David Z. Chow, Victorine V. Muse, Staci M. Gagne, Carol C. Wu, Justin T. Stowell

Research output: Contribution to journalReview articlepeer-review

Abstract

Lymphoma is the most common hematologic malignancy comprising a diverse group of neoplasms arising from multiple blood cell lineages. Any structure of the thorax may be involved at any stage of disease. Imaging has a central role in the initial staging, response assessment, and surveillance of lymphoma, and updated standardized assessment criteria are available to assist with imaging interpretation and reporting. Radiologists should be aware of the modern approaches to lymphoma treatment, the role of imaging in posttherapeutic surveillance, and manifestations of therapy-related complications.

Original languageEnglish (US)
Pages (from-to)67-79
Number of pages13
JournalJournal of Thoracic Imaging
Volume37
Issue number2
DOIs
StatePublished - Mar 1 2022

Keywords

  • Adaptive therapy
  • Bleomycin toxicity
  • Interim positron emission tomography/computed tomography
  • Lymphoma
  • Response evaluation

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Thoracic Imaging Manifestations of Treated Lymphomas: Response Evaluation, Posttherapeutic Sequelae, and Complications'. Together they form a unique fingerprint.

Cite this